289 related articles for article (PubMed ID: 22850567)
1. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
Shimada K; Fujii T; Tsujikawa K; Anai S; Fujimoto K; Konishi N
Clin Cancer Res; 2012 Oct; 18(19):5247-55. PubMed ID: 22850567
[TBL] [Abstract][Full Text] [Related]
2. A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression.
Shimada K; Nakamura M; Anai S; De Velasco M; Tanaka M; Tsujikawa K; Ouji Y; Konishi N
Cancer Res; 2009 Apr; 69(7):3157-64. PubMed ID: 19293182
[TBL] [Abstract][Full Text] [Related]
3. PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis.
Yamato I; Sho M; Shimada K; Hotta K; Ueda Y; Yasuda S; Shigi N; Konishi N; Tsujikawa K; Nakajima Y
Cancer Res; 2012 Sep; 72(18):4829-39. PubMed ID: 22826605
[TBL] [Abstract][Full Text] [Related]
4. ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer.
Tasaki M; Shimada K; Kimura H; Tsujikawa K; Konishi N
Br J Cancer; 2011 Feb; 104(4):700-6. PubMed ID: 21285982
[TBL] [Abstract][Full Text] [Related]
5. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
[TBL] [Abstract][Full Text] [Related]
6. ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.
Fujii T; Shimada K; Anai S; Fujimoto K; Konishi N
Cancer Sci; 2013 Mar; 104(3):321-7. PubMed ID: 23279696
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
Miyake M; Fujimoto K; Anai S; Ohnishi S; Kuwada M; Nakai Y; Inoue T; Matsumura Y; Tomioka A; Ikeda T; Tanaka N; Hirao Y
Oncol Rep; 2011 Mar; 25(3):653-60. PubMed ID: 21206978
[TBL] [Abstract][Full Text] [Related]
8. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
Wang D; Fung JN; Tuo Y; Hu L; Chen C
Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
[TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2006 Dec; 146(3):540-9. PubMed ID: 17100776
[TBL] [Abstract][Full Text] [Related]
11. Expression of TWEAK/Fn14 in neuroblastoma: implications in tumorigenesis.
Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg JO; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjörnsson B
Int J Oncol; 2013 Apr; 42(4):1239-48. PubMed ID: 23443741
[TBL] [Abstract][Full Text] [Related]
12. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
13. anti-tumor effect of AlkB homolog 3 knockdown in hormone- independent prostate cancer cells.
Koike K; Ueda Y; Hase H; Kitae K; Fusamae Y; Masai S; Inagaki T; Saigo Y; Hirasawa S; Nakajima K; Ohshio I; Makino Y; Konishi N; Yamamoto H; Tsujikawa K
Curr Cancer Drug Targets; 2012 Sep; 12(7):847-56. PubMed ID: 22515525
[TBL] [Abstract][Full Text] [Related]
14. TWEAK/Fn14 interaction promotes oxidative stress through NADPH oxidase activation in macrophages.
Madrigal-Matute J; Fernandez-Laso V; Sastre C; Llamas-Granda P; Egido J; Martin-Ventura JL; Zalba G; Blanco-Colio LM
Cardiovasc Res; 2015 Oct; 108(1):139-47. PubMed ID: 26224570
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
17. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
[TBL] [Abstract][Full Text] [Related]
18. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
[TBL] [Abstract][Full Text] [Related]
19. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
Haile WB; Echeverry R; Wu J; Yepes M
J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
